Alcon AG vs BigBearai Holdings Inc — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while BigBearai Holdings Inc trades at $3.33 (market cap $1.60B). The key difference: Alcon AG is far larger — about 22.8× BigBearai Holdings Inc's market cap, and Alcon AG pays a 0.48% dividend while BigBearai Holdings Inc pays none. Which is the better fit depends on your goals.
| ALC | BBAI | |
|---|---|---|
Market Cap | $36.44B | $1.60B |
Sector | Health | Technology |
52-Week High | $90.12 | $8.91 |
52-Week Low | $62.02 | $2.61 |
Enterprise Value | $40.28B | $1.30B |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →